Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-25-004864

Options or other derivatives

  • Chief Operating Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Morgen Eric Chief Operating Officer 2025-02-18 Grant or award · Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X05/form4-02202025_090258.xml…